Title:
Immune mechanisms in inflammatory bowel disease
Series:
Advances in experimental medicine and biology, 579
Publication Information:
New York, NY : Eurekah.com and Springer Science+Business Media, 2006.
ISBN:
9780387337784
Added Corporate Author:
Electronic Access:
Full Text
Genre:
DSP_RESTRICTION_NOTE:
Accessible within UTM campus
Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | EB000152 | EB 000152 | Electronic Book | 1:EBOOK | Searching... |
On Order
Summary
Summary
Immune Mechanisms in Inflammatory Bowel Disease is a highly, concise update of the most recent advances in the immunobiology, genetics and microbiology related to Inflammatory Bowel Disease. This book broadly treats the topics that lead to understanding of the pathogenesis of this disease in an organized, systematic approach.
Table of Contents
1 Structure and Function of the Gut Mucosal Immune System | p. 1 |
Introduction | p. 1 |
Intraepithelial Lymphocytes (IEL) | p. 1 |
Lamina Propria Lymphocytes (LPL) | p. 3 |
Lymphocyte-Filled Villi (LFV) | p. 4 |
Cryptopatches (CP) | p. 5 |
Isolated Lymphoid Follicles (DLF) | p. 5 |
Peyer's Patches (PP) | p. 6 |
Lymphoid Structures in the Large Intestine | p. 7 |
Mesenteric Lymph Nodes, Part of the Gut Immune System | p. 7 |
Gut Lymphatics | p. 8 |
Liver-Also a Part of the Gut Immune System? | p. 8 |
Dynamics in the Gut Immune System | p. 9 |
Conclusions | p. 9 |
Note Added in Proof | p. 9 |
2 Functional Aspects of the Mucosal Immune System | p. 15 |
Phenotypically and Functionally Unique Lymphocyte Populations in the Gut Associated Lymphoid Tissue | p. 15 |
Mechanisms Governing Non-Responsiveness to Food Proteins and Commensal Bacteria | p. 18 |
3 Recent Progress in Inflammatory Bowel Disease Genetics | p. 24 |
Introduction | p. 24 |
IBD Epidemiology | p. 24 |
The Human Genome Project and the Challenge of Complex Genetic Disorders | p. 25 |
Linkage Studies in IBD | p. 26 |
Association Studies in IBD | p. 27 |
Future Directions | p. 30 |
4 Microbial and Dietary Factors in the Pathogenesis of Chronic, Immune-Mediated Intestinal Inflammation | p. 35 |
Introduction | p. 35 |
Evidence of Bacterial Induction and Maintenance of Intestinal Inflammation | p. 38 |
Induction of Mucosal Immune Responses by Bacterial and Dietary Antigens and Adjuvants | p. 42 |
Conclusion | p. 48 |
5 Experimental Models of Mucosal Inflammation | p. 55 |
Introduction | p. 55 |
General Features of Models of Mucosal Inflammation | p. 56 |
Representative Models of Mucosal Inflammation | p. 68 |
Tabular Summary of Models of Mucosal Inflammation | p. 80 |
Conclusion | p. 80 |
6 Overview of Role of the Immune System in the Pathogenesis of Inflammatory Bowel Disease | p. 98 |
Abstract | p. 98 |
Introduction | p. 98 |
Crohn's Disease, but Not Ulcerative Colitis Bears the Stigmata of a Th1 Mediated Immune Response | p. 99 |
The Role of T Cells in Ulcerative Colitis | p. 100 |
The Role of Antibody in Ulcerative Colitis | p. 100 |
Nonspecific Effector Mechanisms Down-Stream of the Immune System Cause Tissue Injury in Crohn's Disease and Ulcerative Colitis | p. 102 |
The Immune System Fails to Negatively Regulate in CD and UC | p. 103 |
7 The Role of the Epithelial Barrier in Inflammatory Bowel Disease | p. 108 |
Introduction | p. 108 |
Bacteria and the Epithelium | p. 108 |
Bacteria and IBD | p. 109 |
The Epithelial Cell as Effector Cell in IBD | p. 110 |
Luminal Antigens, Fate and Processing | p. 112 |
IEC and Mucosal Barrier Function/Permeability | p. 113 |
Conclusion | p. 113 |
8 Involvement of Dendritic Cells in the Pathogenesis of Inflammatory Bowel Disease | p. 117 |
Introduction | p. 117 |
Current Views on Dendritic Cell Biology | p. 117 |
Intestinal Dendritic Cells | p. 119 |
Dendritic Cells in Inflammatory Bowel Disease | p. 122 |
Intestinal Macrophages | p. 126 |
Intestinal Macrophages in IBD | p. 126 |
Summary | p. 127 |
9 Alterations of T Lymphocytes in Inflammatory Bowel Diseases | p. 133 |
CD4[superscript +] T Cell Subsets in the Intestine | p. 134 |
Intestinal T Effector Cells | p. 136 |
Th2 Effectors in IBD | p. 136 |
Intestinal T Regulatory Cells | p. 138 |
CD4[superscript +]CD45RB[superscript Io] T Cells | p. 138 |
T-Regulatory-1 Cells (Tr1) | p. 139 |
T-Helper-3 Cells (Th3) | p. 139 |
[alpha subscript E Beta subscript 7 superscript +] T Cells | p. 140 |
What Drives Effector and Regulatory T Cells in IBD? | p. 141 |
Conclusion | p. 143 |
10 The B-Cell System in Inflammatory Bowel Disease | p. 149 |
Abstract | p. 149 |
Introduction | p. 150 |
B Cell-Mediated Mucosal Homeostasis in the Normal Gut | p. 150 |
Humoral Immunity and Immune Exclusion in IBD Lesions | p. 152 |
Local Production of Antibodies to the Indigenous Gut Flora in IBD | p. 153 |
Local Production of Anti-Epithelial IgG1 Autoantibodies in Ulcerative Colitis | p. 154 |
Local Production and Diagnostic Aid of Other (Auto)Antibodies in IBD | p. 156 |
Mechanisms for Induction of Local Proinflammatory B-Cell Responses | p. 157 |
IBD Apparently Reflects Break of Oral Tolerance against Indigenous Bacteria | p. 161 |
11 Alterations of Mesenchymal and Endothelial Cells in Inflammatory Bowel Diseases | p. 168 |
Abstract | p. 168 |
Introduction | p. 168 |
Mesenchymal Cells | p. 169 |
Smooth Muscle Cells | p. 169 |
Fibroblasts and Myofibroblasts | p. 169 |
Endothelial Cells | p. 170 |
Human Intestinal Microvascular Endothelial Cells | p. 171 |
Integration of Intestinal Immune-Nonimmune Cell Interactions by the CD40/CD40 Ligand System | p. 172 |
12 Role of Mast Cells and Eosinophils in Neuroimmune Interactions Regulating Mucosal Inflammation in Inflammatory Bowel Disease | p. 177 |
Introduction | p. 177 |
Intestinal Mast Cells and Eosinophils | p. 178 |
Role of Mast Cells and Eosinophils in Intestinal Inflammation | p. 182 |
Structure and Function of The Enteric Nervous System | p. 184 |
Mechansims of Mast Cell / Eosinophil-Neuroimmune-Crosstalk in the Gut | p. 186 |
Neurophysiological Effects of Mast Cell and Eosinophil Activation | p. 191 |
Alterations of Neuroimmune-Crosstalk in IBD | p. 194 |
Conclusions | p. 197 |
13 Multiparameter Analysis of Immunogenetic Mechanisms in Clinical Diagnosis and Management of Inflammatory Bowel Disease | p. 209 |
Abstract | p. 209 |
NOD2 and Innate Anti-Microbial Processes in IBD Diagnosis | p. 209 |
Anti-Microbial Antibodies and Adaptive Immune Components in IBD Diagnosis | p. 211 |
Autoantibodies in IBD Diagnosis | p. 213 |
Multiparameter Analysis of Immunogenetic Traits in IBD Diagnosis | p. 213 |
14 The Role of Probiotics and Antibiotics in Regulating Mucosal Inflammation | p. 219 |
Abstract | p. 219 |
Probiotics: Animal Studies and Clinical Trials | p. 219 |
Probiotics: Mechanisms | p. 220 |
Antibiotics: Animal Studies and Clinical Trials | p. 221 |
Antibiotics: Mechanisms | p. 221 |
General Problems | p. 222 |
Perspectives | p. 222 |
15 From Immunogenic Mechanisms to Novel Therapeutic Approaches in Inflammatory Bowel Disease | p. 227 |
Abstract | p. 227 |
Introduction | p. 227 |
Genetic Factors | p. 228 |
Physiological "Hyporeactivity" of the Intestinal Immune System | p. 229 |
Activation of the Mucosal Immune System in IBD | p. 229 |
Novel Therapeutic Approaches | p. 234 |
Concluding Remarks | p. 238 |
Index | p. 243 |